Ginsenoside Rg1 ameliorates sepsis-induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells
- PMID: 35774015
- DOI: 10.1002/JLB.1A0422-211R
Ginsenoside Rg1 ameliorates sepsis-induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells
Abstract
Acute kidney injury (AKI) represents a prevailing complication of sepsis, and its onset involves ferroptosis. Ginsenoside Rg1 exerts a positive effect on kidney diseases. This study explored the action of ginsenoside Rg1 in sepsis-induced AKI (SI-AKI) by regulating ferroptosis in renal tubular epithelial cells (TECs). Sepsis rat models were established using cecal ligation and puncture (CLP) and cell models were established by treating human renal TECs (HK-2) with LPS to induce ferroptosis. Serum creatinine (SCr) and blood urea nitrogen (BUN) and urine KIM1 contents in rats were determined by ELISA kits. Kidney tissues were subjected to immunohistochemical and H&E stainings. Iron concentration, malondialdehyde (MDA), glutathione (GSH), and ferroptosis-related protein (ferritin light chain [FTL], ferritin heavy chain [FTH], GSH peroxidase 4 [GPX4], and Ferroptosis suppressor protein 1 [FSP1]) levels in kidney tissues and HK-2 cells were measured using ELISA kits and Western blotting. HK-2 cell viability was detected by cell counting kit-8, and cell death was observed via propidium iodide staining. Reactive oxygen species accumulation in cells was detected using C11 BODIPY 581/591 as a molecular probe. In CLP rats, ginsenoside Rg1 reduced SCr, BUN, KIM1, and NGAL levels, thus palliating SI-AKI. Additionally, ginsenoside Rg1 decreased iron content, FTL, FTH, and MDA levels, and elevated GPX4, FSP1, and GSH levels, thereby inhibiting lipid peroxidation and ferroptosis. Moreover, FSP1 knockdown annulled the inhibition of ginsenoside Rg1 on ferroptosis. In vitro experiments, ginsenoside Rg1 raised HK-2 cell viability and lowered iron accumulation and lipid peroxidation during ferroptosis, and its antiferroptosis activity was dependent on FSP1. Ginsenoside Rg1 alleviates SI-AKI, possibly resulting from inhibition of ferroptosis in renal TECs through FSP1.
Keywords: FSP1; HK-2 cells; LPS; acute kidney injury; cecal ligation and puncture; ferroptosis; ginsenoside Rg1; sepsis.
©2022 Society for Leukocyte Biology.
Similar articles
-
Ginsenoside Rg1 Suppresses Ferroptosis of Renal Tubular Epithelial Cells in Sepsis-induced Acute Kidney Injury via the FSP1-CoQ10- NAD(P)H Pathway.Curr Med Chem. 2024;31(15):2119-2132. doi: 10.2174/0929867330666230607125054. Curr Med Chem. 2024. PMID: 37287288
-
Dexmedetomidine inhibits ferroptosis and attenuates sepsis-induced acute kidney injury via activating the Nrf2/SLC7A11/FSP1/CoQ10 pathway.Redox Rep. 2024 Dec;29(1):2430929. doi: 10.1080/13510002.2024.2430929. Epub 2024 Nov 24. Redox Rep. 2024. PMID: 39581576 Free PMC article.
-
Andrographolide attenuates sepsis-induced acute kidney injury by inhibiting ferroptosis through the Nrf2/FSP1 pathway.Free Radic Res. 2024 Mar;58(3):156-169. doi: 10.1080/10715762.2024.2330413. Epub 2024 Mar 22. Free Radic Res. 2024. PMID: 38478853
-
Research progress of traditional Chinese medicines in regulating acute kidney injury-related ferroptosis: a literature review.Int Urol Nephrol. 2025 May;57(5):1601-1608. doi: 10.1007/s11255-024-04302-3. Epub 2024 Dec 16. Int Urol Nephrol. 2025. PMID: 39680293 Free PMC article. Review.
-
Targeting ferroptosis: a new therapeutic opportunity for kidney diseases.Front Immunol. 2024 Jul 3;15:1435139. doi: 10.3389/fimmu.2024.1435139. eCollection 2024. Front Immunol. 2024. PMID: 39021564 Free PMC article. Review.
Cited by
-
Alliin mitigates the acute kidney injury by suppressing ferroptosis via regulating the Nrf2/GPX4 axis.Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1521-1533. doi: 10.1007/s00210-024-03343-w. Epub 2024 Aug 7. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39112793
-
Ginsenoside Rg1 Suppresses Ferroptosis of Renal Tubular Epithelial Cells in Sepsis-induced Acute Kidney Injury via the FSP1-CoQ10- NAD(P)H Pathway.Curr Med Chem. 2024;31(15):2119-2132. doi: 10.2174/0929867330666230607125054. Curr Med Chem. 2024. PMID: 37287288
-
Exploring Liraglutide's mechanism in reducing renal fibrosis: the Fsp1-CoQ10-NAD(P)H pathway.Sci Rep. 2025 Jan 12;15(1):1754. doi: 10.1038/s41598-025-85658-z. Sci Rep. 2025. PMID: 39799153 Free PMC article.
-
EP300-mediated H3 acetylation elevates MTHFD2 expression to reduce mitochondrial dysfunction in lipopolysaccharide-induced tubular epithelial cells.Ren Fail. 2024 Dec;46(2):2369342. doi: 10.1080/0886022X.2024.2369342. Epub 2024 Sep 4. Ren Fail. 2024. PMID: 39230047 Free PMC article.
-
Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases.Cell Death Dis. 2023 Sep 22;14(9):628. doi: 10.1038/s41419-023-06144-w. Cell Death Dis. 2023. PMID: 37739961 Free PMC article. Review.
References
REFERENCES
-
- Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021;18:424-434.
-
- Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14:417-427.
-
- May CN, Bellomo R, Lankadeva YR. Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19. Br J Pharmacol. 2021;178:3864-3868.
-
- Cheng C, Yu X. Research progress in chinese herbal medicines for treatment of sepsis: pharmacological action, phytochemistry, and pharmacokinetics. Int J Mol Sci. 2021;22.
-
- Lei W, Liu D, Sun M, et al. Targeting STAT3: a crucial modulator of sepsis. J Cell Physiol. 2021;236:7814-7831.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous